These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5467196)

  • 1. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh
    Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems in curing diffuse toxic goiter].
    Potin VV; Khramtsova VIa; Shliakhtina LG
    Sov Med; 1978 Jun; (6):18-21. PubMed ID: 580976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxic adenoma of the thyroid (study of 120 cases)].
    Papalia D; Vigneri R; Motta L
    Folia Endocrinol; 1968 Aug; 21(4):501-28. PubMed ID: 5757117
    [No Abstract]   [Full Text] [Related]  

  • 6. Euthyroid hyperthyroxinemia and inappropriate secretion of thyrotropin. Recognition and diagnosis.
    Jackson JA; Verdonk CA; Spiekerman AM
    Arch Intern Med; 1987 Jul; 147(7):1311-3. PubMed ID: 3111399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy and Basedow's disease].
    Iino S; Watanabe T; Ban Y
    Nihon Rinsho; 1971 May; 29(5):1360-5. PubMed ID: 4103638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131].
    Slukhaĭ IuF
    Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hypothalamo-hypophyseo-thyroid system in relatives of patients with diffuse toxic goiter].
    Navarro Despaigne D; Speck Garzón P; Alávez Martín E
    Rev Clin Esp; 1985 Apr; 176(6):299-301. PubMed ID: 3839088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radioisotopic indices of thyroid gland function in diffuse toxic goiter in the central Tien Shan mountains].
    Israilov AI; Kaliuzhnyĭ IT
    Zdravookhr Kirg; 1977; (2):20-3. PubMed ID: 17970
    [No Abstract]   [Full Text] [Related]  

  • 11. [The thyroid gland function at remote periods after I-131 treatment of patients with thyrotoxicosis].
    Dybovyĭ ED; Voronenko TV
    Probl Endokrinol (Mosk); 1967; 13(3):8-22. PubMed ID: 5633231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of oxygen on thyroid function in patients with diffuse toxic goiter].
    Khomenko DG
    Klin Khir (1962); 1977 Oct; (10):87. PubMed ID: 579242
    [No Abstract]   [Full Text] [Related]  

  • 13. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
    Werner SC; Feind CR; Aida M
    N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the active severe eye changes of Graves' disease.
    Werner SC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
    Anestiadi ZG
    Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-morphologic comparisons in 2-stage strumectomy in patients with acute toxic goiter].
    Gracheva KP; Odinokova VA
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):21-3. PubMed ID: 5537960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical study of the treatment of Grave's disease (author's transl)].
    Gompel A; Krivitzky A; Delzant G; Sebaoun J; Modigliani E
    Ann Med Interne (Paris); 1979; 130(6-7):331-5. PubMed ID: 582884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Operative treatment of Graves' disease: supersubtotal resection of the thyroid gland].
    Kurihara H
    Vestn Khir Im I I Grek; 2006; 165(3):28-30. PubMed ID: 16881170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
    Charkes ND
    J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.